Intestinal Toxicity Assessment with Patient-Derived Organoids
liamisc2023-01-11T19:10:00-05:00Cell & Molecular Biology, Pharmacology, Toxicology|
Dr. Martin Stahl describes the use of patient-derived intestinal organoids to assess the toxicity of potential therapeutic compounds and study barrier function in a human-specific model system.